Contrast Media Clinical Trial
Official title:
Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Primovist/Eovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
Patients with moderate to severe renal impairment scheduled for a magnetic resonance imaging
(MRI) scan and injection with a contrast agent, Primovist/Eovist, will be asked to
participate.
The administration of contrast agents that contain gadolinium such as Primovist/Eovist might
increase a potential risk to develop a rare condition called nephrogenic systemic fibrosis
(NSF) in patients with renal impairment. This study is to assess the potential risk to
develop NSF in patients with renal impairment after the administration of Primovist/Eovist.
Patients who are enrolled in this study will receive a Primovist/Eovist enhanced MRI scan
which was prescribed by the referring doctor. After the MRI scan the patient will be
included in a two year follow-up period to assess if signs or symptoms suggestive of NSF
have appeared.
Adverse events data will be reported in Adverse Events section. ;
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Suspended |
NCT01365780 -
Hyperbaric Oxygen Therapy in Distal Radius Fractures: Can it Shorten Recovery Time and Increase Fracture Healing?
|
N/A | |
| Active, not recruiting |
NCT04813432 -
Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas
|
||
| Withdrawn |
NCT00718055 -
Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients
|
Phase 4 | |
| Completed |
NCT00716703 -
CT Scan Using IV Contrast Alone for Pediatric Appendicitis
|
N/A | |
| Completed |
NCT02575092 -
The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT02261909 -
New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients
|
||
| Recruiting |
NCT04373564 -
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
|
Phase 4 | |
| Completed |
NCT02155218 -
Improving the Concentration of MR Contrast in the Arteries
|
N/A | |
| Withdrawn |
NCT03806725 -
Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography
|
||
| Completed |
NCT01159717 -
CT Versus CEUS Findings of Complex Cystic Renal Lesions
|
N/A | |
| Completed |
NCT04249479 -
Contrast Media Temperature and Patient Comfort in CT of the Abdomen
|
N/A | |
| Terminated |
NCT00384995 -
Bicarbonate v Saline to Prevent Contrast Nephropathy
|
Phase 4 | |
| Completed |
NCT03735706 -
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.
|
N/A |